Neuraptive Website Main Banner .png

THE FUTURE OF
NERVE REPAIR

Better solutions for physicians and patients

VISION

Developing Better Solutions For Physicians And Patients

Neuraptive is developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve injuries.

Illustration of the human arm anatomy representing nerves, bones and ligaments..jpg

RESEARCH & TECHNOLOGY

The Future of Peripheral Nerve Repair and Recovery

PEG-FUSION 

Neuraptive has in-licensed technology from the University of Texas at Austin (UT) protecting a novel fusion system for repairing severed peripheral nerves. This technology improves both the speed and outcomes of peripheral nerve injuries (PNI).

Neuraptive Website Banner 1 Nerve Fusion.png
Neuraptive Website Banner 2 Drug Delivery Device.png
Neuraptive Website Banner 2 Drug Delivery Device.png

DRUG DELIVERY DEVICE

A specialized device focusing on the delivery of active agents for topical administration directly on the nerve.

MICROSURGICAL INSTRUMENTS

Neuraptive is developing nerve-specific microsurgical instruments that address current product limitations in the field of nerve repair.

Neuraptive Website Banner 3 Microsurgical Instruments.png
clinic, profession, people, healthcare and medicine concept - group of medics or doctors w

THE NEURAPTIVE DIFFERENCE

An innovative technology potentially revolutionizing nerve repair.

Neuraptive has developed a surgical treatment kit for peripheral nerves after traumas or peripheral nerve reconstruction procedures.  NTX-001 leverages the 505(b)(2) development pathway (comprised of previously approved pharmaceutical ingredients) presented in sterile solutions.

Neuraptive Website Banner 4 By The Numbers.png

By The Numbers

$2.7B

U.S. MARKET

OPPORTUNITY

20M

U.S. LIVES

TO IMPACT

INDUSTRY

Our
Partner

The in-licensed and issued patent estate from the University of Texas protects the method of repairing nerves embodied in NTX-001. We have invented a novel delivery device, a formulation and a kit design for which separate patent applications have been filed. Patent protections is expected to extend through 2038.

Neuraptive Partners 2.png

UNIVERSITY OF

TEXAS AUSTIN

INVESTORS

Want to learn about upcoming investment opportunities?

 

Contact us for investor relations information.

OPPORTUNITY

Market opportunities include acute trauma patients as well as patients undergoing corrective, reconstructive, and elective surgeries.

 

Reimbursements for nerve repair procedures are well-established and significant. Neuraptive’s products address a ~$2.7B US and >$5.5B global market opportunity.